Skip to Main Content

Paper Details

Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer.
Clin Cancer Res
47
2022
Adagrasib, BM, Brain Metastases, H23-Luc, KRAS, KRAS-mutant NSCLC, KRASG12C, KRASG12C-Mutant Non-Small Cell Lung Cancer, KRASG12C-mutant NSCLC, KRASG12C-mutant NSCLC xenografts, LU65-Luc, LU99-Luc, MRTX849, Mice, NSCLC, Patients, adagrasib, brain metastases, non-small cell lung cancer, patients, tumor
Author NameAffiliation
Subba R DigumarthyMassachusetts General Hospital, Harvard Medical School
Priscilla K BrastianosMassachusetts General Hospital, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2